ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,565
-0,38%
Bitcoin
59 924,46
-1,12%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PharmaCyte Biotech Inc (PMCB)

  7. PharmaCyte Biotech Inc (PMCB) Actualités

PMCB PharmaCyte Biotech Inc

2,12
0,00 (0,00%)
30 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
PharmaCyte Biotech Inc PMCB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 2,12 22:55:32
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,12 2,12 2,20 2,12 2,12
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
14/2/202421:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202415:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/12/202323:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/11/202323:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/11/202322:00EDGAR2Form 8-K - Current report
22/11/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15/11/202314:30BWPharmaCyte Biotech Acquires $5 Million Stake in Emerging..
09/11/202323:25EDGAR2Form 8-K - Current report
31/10/202314:15BWPharmaCyte Biotech Provides Corporate Update on..
21/9/202323:04EDGAR2Form S-3/A - Registration statement under Securities Act of..
18/9/202312:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/9/202323:00EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
12/9/202303:56EDGAR2Form S-3/A - Registration statement under Securities Act of..
07/9/202322:05EDGAR2Form 8-K - Current report
04/8/202322:40EDGAR2Form S-3/A - Registration statement under Securities Act of..
04/8/202322:01EDGAR2Form 8-K - Current report
31/7/202323:18EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
31/7/202322:42EDGAR2Form DEF 14A - Other definitive proxy statements
19/7/202316:28EDGAR2Form PRE 14A - Other preliminary proxy statements
15/6/202315:15BWPharmaCyte Biotech Announces Final Results of Tender Offer
11/5/202314:30BWPharmaCyte Biotech Announces Cash Tender Offer for up to..

Dernières Valeurs Consultées

NASDAQ
PMCB
PharmaCyte Biotech
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés